Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cutler

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|March 1, 1984
Alterations in auditory processing of speech stimuli during aging in healthy subjectsC L Grady, A M Grimes, A Pikus, et al.
The New England Journal of Medicine|March 14, 1985
Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's diseaseN R Cutler, J V Haxby, P K Narang, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Low dose bromocriptine: a study of acute effects in chronic mediated schizophrenicsN R Cutler, D V Jeste, C A Kaufmann, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1991
A new assessment tool for neuropsychopharmacologic research: the Computerized Neuropsychological Test BatteryA E Veroff, N R Cutler, J J Sramek, et al.
Life Sciences|May 19, 1998
Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose studyN R Cutler, S S Jhee, P Cyrus, et al.
Life Sciences|January 1, 1995
A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesteraseJ J Sramek, G A Block, S A Reines, et al.
The American Journal of Psychiatry|December 1, 1986
Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppressionA Roy, H Agren, D Pickar, et al.
Journal of Clinical Pharmacology|February 1, 1995
Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable anginaN R Cutler, J Eff, G Fromell, et al.
Journal of Clinical Pharmacology|May 1, 1993
Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test batteryJ C Fleishaker, T A Sisson, J J Sramek, et al.
Clinical Pharmacokinetics|March 1, 1992
Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonismN R Cutler, S A Reines, L F McLean, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|March 1, 1984
Alterations in auditory processing of speech stimuli during aging in healthy subjectsC L Grady, A M Grimes, A Pikus, et al.
The New England Journal of Medicine|March 14, 1985
Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's diseaseN R Cutler, J V Haxby, P K Narang, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Low dose bromocriptine: a study of acute effects in chronic mediated schizophrenicsN R Cutler, D V Jeste, C A Kaufmann, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1991
A new assessment tool for neuropsychopharmacologic research: the Computerized Neuropsychological Test BatteryA E Veroff, N R Cutler, J J Sramek, et al.
Life Sciences|May 19, 1998
Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose studyN R Cutler, S S Jhee, P Cyrus, et al.
Life Sciences|January 1, 1995
A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesteraseJ J Sramek, G A Block, S A Reines, et al.
The American Journal of Psychiatry|December 1, 1986
Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppressionA Roy, H Agren, D Pickar, et al.
Journal of Clinical Pharmacology|February 1, 1995
Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable anginaN R Cutler, J Eff, G Fromell, et al.
Journal of Clinical Pharmacology|May 1, 1993
Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test batteryJ C Fleishaker, T A Sisson, J J Sramek, et al.
Clinical Pharmacokinetics|March 1, 1992
Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonismN R Cutler, S A Reines, L F McLean, et al.
Pageof 17